financetom
Business
financetom
/
Business
/
JPMorgan names CEO contender Jennifer Piepszak as its operations chief
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
JPMorgan names CEO contender Jennifer Piepszak as its operations chief
Jan 14, 2025 5:56 AM

(Reuters) -JPMorgan Chase ( JPM ) on Tuesday promoted insider Jennifer Piepszak, seen as a strong contender for CEO Jamie Dimon's role, as its chief operating officer in place of Daniel Pinto, who will retire at the end of 2026.

Piepszak is currently co-CEO of its commercial and investment bank. In her three decades at JPMorgan ( JPM ), she served as its finance chief from 2019 to 2021 and ran card services and business banking. The executive also spent 17 years climbing the ranks in investment banking.

Pinto, who will relinquish his responsibilities as of June 30, was previously cited by the board as the executive who could step in for the CEO in the near term, as he did in 2020 when Dimon had an emergency heart surgery.

Other than Piepszak, top contenders for the CEO job include Troy Rohrbaugh, who heads the commercial and investment bank, Marianne Lake, CEO of consumer and community banking and Mary Erdoes, CEO of asset and wealth management.

(Reporting by Niket Nishant and Manya Saini in Bengaluru; Editing by Arun Koyyur)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Alx Oncology Holdings Insider Sold Shares Worth $710,195, According to a Recent SEC Filing
Alx Oncology Holdings Insider Sold Shares Worth $710,195, According to a Recent SEC Filing
Apr 18, 2024
04:52 PM EDT, 04/18/2024 (MT Newswires) -- Jaume Pons, Director, President & Chief Scientific Officer, on April 16, 2024, sold 50,000 shares in Alx Oncology Holdings ( ALXO ) for $710,195. Following the Form 4 filing with the SEC, Pons has control over a total of 604,205 shares of the company, with 604,205 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1810182/000141588924011128/xslF345X03/form4-04182024_080417.xml ...
T. Rowe Price says 2018 Tesla pay aligned with investor interests
T. Rowe Price says 2018 Tesla pay aligned with investor interests
Apr 18, 2024
April 18 (Reuters) - Mutual fund firm T. Rowe Price ( TROW ) said Elon Musk's record-breaking 2018 pay package from Tesla demonstrated strong alignment with the interests of investors at the electric carmaker. The comments from the 10th-largest Tesla investor mark important support after a Delaware judge in January voided the $56 billion package as being unfair to investors...
Nordstrom to evaluate founding family's interest in take-private deal
Nordstrom to evaluate founding family's interest in take-private deal
Apr 18, 2024
(Reuters) -Nordstrom said the founding family behind the department store chain had shown an interest in exploring a go-private deal, and the company's board had formed a special committee of independent directors to look into it. The move by CEO Erik Nordstrom and President Pete Nordstrom comes at a time when department store chains across the U.S. are grappling with...
Inspire Medical Systems Insider Sold Shares Worth $3,450,450, According to a Recent SEC Filing
Inspire Medical Systems Insider Sold Shares Worth $3,450,450, According to a Recent SEC Filing
Apr 18, 2024
04:47 PM EDT, 04/18/2024 (MT Newswires) -- Richard Buchholz, Chief Financial Officer, on April 17, 2024, sold 15,000 shares in Inspire Medical Systems ( INSP ) for $3,450,450. Following the Form 4 filing with the SEC, Buchholz has control over a total of 28,271 shares of the company, with 28,271 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1609550/000110465924048900/xslF345X03/tm2412174-1_4seq1.xml ...
Copyright 2023-2026 - www.financetom.com All Rights Reserved